Insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Novelion Therapeutics Inc. (QLTI) since 2014 are shown in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Novelion Therapeutics Inc.. Table 2 shows the detailed insider transactions. This company's CIK number is 827809.
Total stock buying since 2014: $1,528,759.
Total stock sales since 2014: $63,224,880.
Total stock option exercises since 2014: $785,150.
| Insider Buying | Insider Sales | Option Exercises | ||||
|---|---|---|---|---|---|---|
| Year | Shares | Value | Shares | Value | Shares | Value |
| 2019 | 205,787 | $143,039 | 0 | $0 | 0 | $0 |
| 2018 | 0 | $0 | 450,001 | $402,985 | 0 | $0 |
| 2017 | 2,861 | $25,980 | 0 | $0 | 12,258 | $0 |
| 2016 | 133,496 | $206,537 | 0 | $0 | 0 | $0 |
| 2015 | 306,400 | $1,045,268 | 16,428,089 | $57,021,895 | 286,500 | $785,150 |
| 2014 | 30,000 | $107,935 | 1,000,000 | $5,800,000 | 14,000 | $0 |
| Trading Period | Insider Buying | Insider Sales | Option Exercises | |||
|---|---|---|---|---|---|---|
| year-month | Shares | Value | Shares | Value | Shares | Value |
| 2019-12 | 15,942 | $11,115 | 0 | $0 | 0 | $0 |
| 2019-11 | 89,845 | $67,024 | 0 | $0 | 0 | $0 |
| 2019-10 | 100,000 | $64,900 | 0 | $0 | 0 | $0 |
| 2018-12 | 0 | $0 | 450,001 | $402,985 | 0 | $0 |
| 2017-09 | 0 | $0 | 0 | $0 | 337 | $0 |
| 2017-06 | 2,500 | $22,750 | 0 | $0 | 0 | $0 |
| 2017-05 | 361 | $3,230 | 0 | $0 | 11,287 | $0 |
| 2017-04 | 0 | $0 | 0 | $0 | 178 | $0 |
| 2017-01 | 0 | $0 | 0 | $0 | 456 | $0 |
| 2016-09 | 133,496 | $206,537 | 0 | $0 | 0 | $0 |
| 2015-12 | 18,400 | $45,908 | 0 | $0 | 0 | $0 |
| 2015-06 | 288,000 | $999,360 | 16,428,089 | $57,021,895 | 286,500 | $785,150 |
| 2014-12 | 30,000 | $107,935 | 0 | $0 | 14,000 | $0 |
| 2014-07 | 0 | $0 | 1,000,000 | $5,800,000 | 0 | $0 |
| Trade Date | Insider Name | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2019-12-12 | Stonepine Capital, L.p. | Buy | 1,000 | .70 | 700 |
| 2019-12-11 | Stonepine Capital, L.p. | Buy | 40 | .69 | 27 |
| 2019-12-10 | Stonepine Capital, L.p. | Buy | 5,202 | .69 | 3,599 |
| 2019-12-09 | Stonepine Capital, L.p. | Buy | 4,500 | .70 | 3,150 |
| 2019-12-06 | Stonepine Capital, L.p. | Buy | 40 | .70 | 28 |
| 2019-12-05 | Stonepine Capital, L.p. | Buy | 5,160 | .70 | 3,611 |
| 2019-11-22 | Stonepine Capital, L.p. | Buy | 89,845 | .75 | 67,024 |
| 2019-10-11 | Stonepine Capital, L.p. | Buy | 100,000 | .65 | 64,900 |
| 2018-12-27 | Kotler Kevin | Sale | 171,116 | .86 | 147,501 |
| 2018-12-26 | Kotler Kevin | Sale | 278,485 | .92 | 255,092 |
| 2018-12-24 | Kotler Kevin | Sale | 400 | .98 | 392 |
| 2017-09-17 | Harshbarger Benjamin (General Counsel) | Option Ex | 337 | .00 | 0 |
| 2017-06-12 | Stern Donald K (Director) | Buy | 2,500 | 9.10 | 22,750 |
| 2017-05-15 | Harshbarger Benjamin (General Counsel) | Option Ex | 717 | .00 | 0 |
| 2017-05-15 | Aryeh Jason (Director) | Buy | 361 | 8.95 | 3,230 |
| 2017-05-09 | Buono Linda (Sr. VP, Human Resources) | Option Ex | 274 | .00 | 0 |
| 2017-05-09 | Louis Roger (See Remarks) | Option Ex | 547 | .00 | 0 |
| 2017-05-09 | Harshbarger Benjamin (General Counsel) | Option Ex | 724 | .00 | 0 |
| 2017-05-09 | Szela Mary T (Chief Executive Officer) | Option Ex | 6,632 | .00 | 0 |
| 2017-05-09 | Perry Gregory D (See Remarks) | Option Ex | 2,393 | .00 | 0 |
| 2017-04-01 | Harshbarger Benjamin (General Counsel) | Option Ex | 178 | .00 | 0 |
| 2017-01-27 | Smith Sandford D (Director) | Option Ex | 456 | .00 | 0 |
| 2016-09-15 | Stonepine Capital, L.p. | Buy | 14,928 | 1.55 | 23,138 |
| 2016-09-14 | Stonepine Capital, L.p. | Buy | 56,864 | 1.55 | 88,252 |
| 2016-09-13 | Stonepine Capital, L.p. | Buy | 61,704 | 1.54 | 95,147 |
| 2015-12-29 | Aryeh Jason | Buy | 18,400 | 2.50 | 45,908 |
| 2015-06-30 | Aryeh Jason (Director) | Option Ex | 50,000 | 3.46 | 172,750 |
| 2015-06-29 | Meckler Jeffrey A (Director) | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-29 | Sabba Stephen L (Director) | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-29 | Thomas John C (Director) | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-29 | Kozarich John W (Director) | Option Ex | 25,000 | 3.48 | 87,125 |
| 2015-06-29 | Cox Geoffrey F (Interim CEO) | Option Ex | 72,500 | 3.64 | 263,900 |
| 2015-06-16 | Axial Capital Master, L.p. | Sale | 7,563,053 | 3.47 | 26,251,356 |
| 2015-06-16 | Assouline, Eliav | Sale | 8,865,036 | 3.47 | 30,770,539 |
| 2015-06-16 | Aryeh Jason (Director) | Buy | 288,000 | 3.47 | 999,360 |
| 2015-06-07 | Meckler Jeffrey A (Director) | Option Ex | 10,000 | .00 | 0 |
| 2015-06-07 | Sabba Stephen L (Director) | Option Ex | 10,000 | .00 | 0 |
| 2015-06-07 | Thomas John C (Director) | Option Ex | 10,000 | .00 | 0 |
| 2015-06-07 | Aryeh Jason (Director) | Option Ex | 20,000 | .00 | 0 |
| 2015-06-07 | Kozarich John W (Director) | Option Ex | 10,000 | .00 | 0 |
| 2015-06-07 | Cox Geoffrey F (Interim CEO) | Option Ex | 4,000 | .00 | 0 |
| 2014-12-22 | Kozarich John W (Director) | Buy | 8,300 | 3.62 | 30,070 |
| 2014-12-19 | Kozarich John W (Director) | Buy | 1,700 | 3.45 | 5,865 |
| 2014-12-18 | Meckler Jeffrey A (Director) | Buy | 20,000 | 3.60 | 72,000 |
| 2014-12-15 | Meckler Jeffrey A (Director) | Option Ex | 2,000 | .00 | 0 |
| 2014-12-15 | Sabba Stephen L (Director) | Option Ex | 2,000 | .00 | 0 |
| 2014-12-15 | Thomas John C (Director) | Option Ex | 2,000 | .00 | 0 |
| 2014-12-15 | Aryeh Jason (Director) | Option Ex | 4,000 | .00 | 0 |
| 2014-12-15 | Kozarich John W (Director) | Option Ex | 2,000 | .00 | 0 |
| 2014-12-15 | Cox Geoffrey F (Int. Chief Executive Officer) | Option Ex | 2,000 | .00 | 0 |
| 2014-07-11 | Schonharting Florian (10% Owner) | Sale | 1,000,000 | 5.80 | 5,800,000 |
Insider trading activities including stock purchases, stock sales, and option exercises of QLTI listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Novelion Therapeutics Inc. (symbol QLTI, CIK number 827809) see the Securities and Exchange Commission (SEC) website.